Pharmacokinetics, Pharmacodynamics, and Safety of Single-dose Sotrovimab in High-risk Pediatric Participants With Mild to Moderate COVID-19
Clinical trial NCT05124210 · TERMINATED
Trial details
- NCT number
- NCT05124210
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-16
- Primary completion
- 2023-06-14
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.